With the normalization of centralized medical procurement, the deepening of DRG/DIP payment reform, and the ongoing anti-corruption campaign in the medical industry, the medical device industry is undergoing profound changes under a combination of policies:

★ Driving large, medium, and small medical device companies to accelerate their expansion into overseas markets and explore new spaces for global development;

★ Forcing the industry to accelerate consolidation and reshuffling, squeezing out inefficient production capacity and market bubbles, and promoting the optimization and upgrading of the industrial structure;

★ Incentivizing companies to increase investment in innovation and R&D, accelerating the process of domestic substitution, and steadily improving the innovation capabilities of domestic medical devices.

★ Under the wave of policies, the traditional medical conference and exhibition model faces challenges—the direct linkage between clinicians and enterprises has weakened, and industry activities that lose clinical participation also lose their core value and vitality.

As an industry benchmark platform focusing on innovative medical devices, the High-Tech Medical Conference (HTMC) has always anchored itself on the dual cores of clinical needs and technological innovation. It has not only attracted a large number of clinical experts and medical institutions to participate deeply, but also included non-public medical institutions and foreign-funded hospitals in its key collaboration efforts. Here, you can participate in high-quality academic forums that bring together leading clinical experts, directly addressing cutting-edge diagnostic and treatment technologies and pain points in clinical applications; you can also encounter numerous domestic and international buyers and explore global cooperation opportunities. Only innovation can attract industry attention; only value can drive long-term cooperation.